Journal
MULTIPLE SCLEROSIS JOURNAL
Volume 27, Issue 4, Pages 636-639Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458520934070
Keywords
Depression; cannabis
Categories
Funding
- Multiple Sclerosis Society of Canada
Ask authors/readers for more resources
A study found that symptoms of depression improved in multiple sclerosis patients after discontinuing cannabis use, even though they were using cannabis to manage their depression. This suggests potential risks of using cannabis in treating depression symptoms in multiple sclerosis patients.
To assess whether symptoms of depression change when people with multiple sclerosis (pwMS) discontinue cannabis use, 40 cognitively impaired pwMS who smoked cannabis almost daily were randomly assigned to either a cannabis continuation (CC) or cannabis withdrawal (CW) group. Both groups were followed for 28 days. All participants completed the Hospital Anxiety and Depression Scale. At day 28 the 11-nor-9-carboxy-Delta(9)-tetrahydro-cannabinol (THCCOOH)/creatinine ratio in the CW group declined to zero (p = 0.0001), but remained unchanged in the CC group (p = 0.709). Depression scores in those pwMS who were using cannabis to manage their depression remained statistically unchanged in the CC group, but declined in the CW group (p = 0.006). Despite pwMS using cannabis to help their mood, depression improved significantly off the drug. Our finding provides a cautionary note in relation to cannabis use in pwMS, at least with respect to depression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available